Permanent Artificial Skin Market: Introduction
- Permanent artificial skin is generally used in case of burn victims with superficial, deep, or partial wounds and chronic & acute wounds. Permanent artificial skin is a skin substitute employed for wound closure in order to replace the layer of the skin, especially at the burn site, permanently. Major advantages of artificial skin substitutes are increased wound healing, flexibility, and prevention of infection at the site of wound. The different types of permanent artificial skin available in the market are epicel, alloderm, and integra. Epicel is also known as cultured epithelial autograft. It is made from the patient’s own skin and cultured for two to three weeks before it is used as a graft. Alloderm is employed to replace damaged soft tissue in case of deep wounds. It cannot be used for large surface areas. Integra is a permanent synthetic artificial skin substitute, which promotes growth of the cells and helps in formation of the red blood cells.
Permanent Artificial Skin Market: Key Trends
- The global permanent artificial skin market is projected to be driven by increase in incidence rate of burn injuries, rise in prevalence rate of chronic & acute wounds such as diabetic foot ulcers, surge in R&D efforts for the development of new products, technological advancements such as sprays for treating burn injuries by using the patient’s own cells for rapid recovery, and increase in health care expenditure in developed as well as developing countries. However, high cost associated with artificial skin implant, stringent regulations regarding launch of new products, and low awareness in low-income economies are anticipated to be major restraints of the global permanent artificial skin market during the forecast period.
- Increase in demand for artificial skin substitutes has led to rise in adoption of expansion strategies by manufactures to expand geographic presence by introducing innovative products in newer regions through strategic collaborations. For instance, on March 4, 2019, AVITA Medical collaborated with COSMOTEC, a subsidiary of M3 Group Company, for marketing and distribution of RECELL in Japan, which is used for the treatment of wounds caused by burns and other injuries. The launch of the product in Japan is anticipated to provide a lucrative opportunity for AVITA Medical, as there has been increase in the patient population suffering from chronic wounds and decubitus ulcers in Japan in the past few years.
- Presently, the world is struggling with the COVID-19 pandemic. COVID-19 leads to pneumonia, severe & acute respiratory disorders, multiple organ failure, and, in severe cases, death. The geriatric population is more prone to COVID-19. The global permanent artificial skin market has experienced sluggish growth during the pandemic.
- Governments of developing countries are making significant investments to modernize health care infrastructure in their respective countries, which is anticipated to increase access to health care. This is expected to drive the demand for permanent artificial skin.
North America to Capture Major Share of Global Permanent Artificial Skin Market
- North America is projected to dominate the global permanent artificial skin market from 2021 to 2031. This is attributed to favorable regulatory environment and increase in incidence of burn injuries, which has led to surge in demand for permanent artificial skin for efficient treatment of severe burns. Manufacturers are looking for opportunities for the development of new products through regular investments in research & development. According to the American Burn Association report, nearly 40,000 patients were hospitalized for burn injuries in the U.S from 2017 to 2018. Similar studies have been reported by other major national organizations for burn injuries. For instance, the Centers for Diseases Control and Prevention reported that around 10,000 individuals in the U.S. succumb every year to infections caused after burn injuries.
- The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to rise in research & developmental activities, increase in government initiatives for improving health care, and surge in focus of key players in building or strengthening presence in the region.
Key Players Operating in Global Permanent Artificial Skin Market
Leading players hold a major share in their respective regions. Growth strategies adopted by these players are likely to drive the global permanent artificial skin market.
Major players operating in the global permanent artificial skin market are:
- AVITA Medical
- Eucare Pharmaceuticals (P) Ltd.
- MiMedx
- Aroa Biosurgery Limited
- Integra LifeSciences
- Mallinckrodt Pharmaceuticals
- Medskin Suwelack
- Misonix
- Organogenesis, Inc.
- Other prominent players
Global Permanent Artificial Skin Market: Research Scope
Global Permanent Artificial Skin Market, by Product Type
- Epidermal Skin
- Dermal Skin
Global Permanent Artificial Skin Market, by End-user
- Hospitals
- Skin Care Centers
- Ambulatory Surgical Centers
- Others
Global Permanent Artificial Skin Market, by Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
